EarlySign’s proprietary machine learning-based solutions analyze many of the “hidden” factors residing in electronic health records, including routine laboratory test results, demographics, medications, and diagnostic codes to accurately identify individuals at higher risk of having or developing a specific disease or condition. These predictive insights create powerful opportunities for early intervention strategies and more effective prioritization of clinical resources. EarlySign’s AI-based software models are in active use by global healthcare systems to help detect and prevent complications associated with high-burden diseases.
